Alternatives to KAHR Medical

A global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases.

Biopharmaceutical company focused on developing and commercializing innovative medicines.

Developing novel diagnostics to predict patient response to immunotherapy.

AI-driven drug discovery platform accelerating breakthrough scientific research.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Biopharmaceutical company targeting neurodegeneration and aging by modulating the immune system.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Mabylon is a biotechnology company focused on developing innovative antibody-based therapies for infectious diseases and cancer.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Early-stage clinical company developing smart targeted radioligands for precision oncology.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Developing engineered biologics to harness the immune system for disease treatment.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A global contract research organization specializing in preclinical and translational oncology research.